150 related articles for article (PubMed ID: 1579470)
1. Synthesis and restriction enzyme analysis of oligodeoxyribonucleotides containing the anti-cancer drug 2',2'-difluoro-2'-deoxycytidine.
Richardson FC; Richardson KK; Kroin JS; Hertel LW
Nucleic Acids Res; 1992 Apr; 20(7):1763-8. PubMed ID: 1579470
[TBL] [Abstract][Full Text] [Related]
2. NMR structure of a gemcitabine-substituted model Okazaki fragment.
Konerding D; James TL; Trump E; Soto AM; Marky LA; Gmeiner WH
Biochemistry; 2002 Jan; 41(3):839-46. PubMed ID: 11790105
[TBL] [Abstract][Full Text] [Related]
3. [Non-clinical studies of gemcitabine--the mode of action and antitumor activities].
Tsukagoshi S
Gan To Kagaku Ryoho; 1999 Feb; 26(3):393-400. PubMed ID: 10065109
[TBL] [Abstract][Full Text] [Related]
4. Molecular effects of 2',2'-difluorodeoxycytidine (Gemcitabine) on DNA replication in intact HL-60 cells.
Ross DD; Cuddy DP
Biochem Pharmacol; 1994 Oct; 48(8):1619-30. PubMed ID: 7980627
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenomics of gemcitabine metabolism: functional analysis of genetic variants in cytidine deaminase and deoxycytidine kinase.
Baker JA; Wickremsinhe ER; Li CH; Oluyedun OA; Dantzig AH; Hall SD; Qian YW; Ring BJ; Wrighton SA; Guo Y
Drug Metab Dispos; 2013 Mar; 41(3):541-5. PubMed ID: 23230131
[TBL] [Abstract][Full Text] [Related]
6. Large scale synthesis of p-benzoquinone-2'-deoxycytidine and p-benzoquinone-2'-deoxyadenosine adducts and their site-specific incorporation into DNA oligonucleotides.
Chenna A; Singer B
Chem Res Toxicol; 1995 Sep; 8(6):865-74. PubMed ID: 7492736
[TBL] [Abstract][Full Text] [Related]
7. Action of 2',2'-difluorodeoxycytidine on DNA synthesis.
Huang P; Chubb S; Hertel LW; Grindey GB; Plunkett W
Cancer Res; 1991 Nov; 51(22):6110-7. PubMed ID: 1718594
[TBL] [Abstract][Full Text] [Related]
8. Effect of a template-located 2',2'-difluorodeoxycytidine on the kinetics and fidelity of base insertion by Klenow (3'-->5'exonuclease-) fragment.
Schy WE; Hertel LW; Kroin JS; Bloom LB; Goodman MF; Richardson FC
Cancer Res; 1993 Oct; 53(19):4582-7. PubMed ID: 8402631
[TBL] [Abstract][Full Text] [Related]
9. Comparison of antineoplastic activity of 2',2'-difluorodeoxycytidine and cytosine arabinoside against human myeloid and lymphoid leukemic cells.
Bouffard DY; Momparler LF; Momparler RL
Anticancer Drugs; 1991 Feb; 2(1):49-55. PubMed ID: 1958852
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of thymidylate synthase by 2',2'-difluoro-2'-deoxycytidine (Gemcitabine) and its metabolite 2',2'-difluoro-2'-deoxyuridine.
Honeywell RJ; Ruiz van Haperen VW; Veerman G; Smid K; Peters GJ
Int J Biochem Cell Biol; 2015 Mar; 60():73-81. PubMed ID: 25562513
[TBL] [Abstract][Full Text] [Related]
11. 2',2'-Difluoro-deoxycytidine (gemcitabine) incorporation into RNA and DNA of tumour cell lines.
Ruiz van Haperen VW; Veerman G; Vermorken JB; Peters GJ
Biochem Pharmacol; 1993 Aug; 46(4):762-6. PubMed ID: 8363650
[TBL] [Abstract][Full Text] [Related]
12. Kinetic studies on 2',2'-difluorodeoxycytidine (Gemcitabine) with purified human deoxycytidine kinase and cytidine deaminase.
Bouffard DY; Laliberté J; Momparler RL
Biochem Pharmacol; 1993 May; 45(9):1857-61. PubMed ID: 8494545
[TBL] [Abstract][Full Text] [Related]
13. Incorporation of gemcitabine and cytarabine into DNA by DNA polymerase beta and ligase III/XRCC1.
Prakasha Gowda AS; Polizzi JM; Eckert KA; Spratt TE
Biochemistry; 2010 Jun; 49(23):4833-40. PubMed ID: 20459144
[TBL] [Abstract][Full Text] [Related]
14. A new, simple method for quantifying gemcitabine triphosphate in cancer cells using isocratic high-performance liquid chromatography.
Nishi R; Yamauchi T; Ueda T
Cancer Sci; 2006 Nov; 97(11):1274-8. PubMed ID: 17034368
[TBL] [Abstract][Full Text] [Related]
15. Difluorodeoxyguanosine: cytotoxicity, metabolism, and actions on DNA synthesis in human leukemia cells.
Gandhi V; Mineishi S; Huang P; Yang Y; Chubb S; Chapman AJ; Nowak BJ; Hertel LW; Plunkett W
Semin Oncol; 1995 Aug; 22(4 Suppl 11):61-7. PubMed ID: 7481847
[TBL] [Abstract][Full Text] [Related]
16. Saturation of 2',2'-difluorodeoxycytidine 5'-triphosphate accumulation by mononuclear cells during a phase I trial of gemcitabine.
Grunewald R; Abbruzzese JL; Tarassoff P; Plunkett W
Cancer Chemother Pharmacol; 1991; 27(4):258-62. PubMed ID: 1998982
[TBL] [Abstract][Full Text] [Related]
17. Concentration changes in gemcitabine and its metabolites after hyperthermia in pancreatic cancer cells assessed using RP-HPLC.
Jin HB; Lu L; Xie L; Yang JF; Zhang XF; Ma SL
Cell Mol Biol Lett; 2019; 24():30. PubMed ID: 31131010
[TBL] [Abstract][Full Text] [Related]
18. Schedule dependence of sensitivity to 2',2'-difluorodeoxycytidine (Gemcitabine) in relation to accumulation and retention of its triphosphate in solid tumour cell lines and solid tumours.
Ruiz van Haperen VW; Veerman G; Boven E; Noordhuis P; Vermorken JB; Peters GJ
Biochem Pharmacol; 1994 Oct; 48(7):1327-39. PubMed ID: 7945430
[TBL] [Abstract][Full Text] [Related]
19. Gemcitabine: metabolism, mechanisms of action, and self-potentiation.
Plunkett W; Huang P; Xu YZ; Heinemann V; Grunewald R; Gandhi V
Semin Oncol; 1995 Aug; 22(4 Suppl 11):3-10. PubMed ID: 7481842
[TBL] [Abstract][Full Text] [Related]
20. Chemical synthesis of 2'-deoxyoligonucleotides containing 5-fluoro-2'-deoxycytidine.
Schmidt S; Pein CD; Fritz HJ; Cech D
Nucleic Acids Res; 1992 May; 20(10):2421-6. PubMed ID: 1598200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
